<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>P53 is known as a determinant of cellular responses to DNA damage, including <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, cell cycle arrest, and DNA repair </plain></SENT>
<SENT sid="1" pm="."><plain>Its role is most easily understood in the context of Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and other <z:mpath ids='MPATH_3'>apoptosis</z:mpath>-prone cell types </plain></SENT>
<SENT sid="2" pm="."><plain>A number of epithelial <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cell types, by contrast, exhibit a higher threshold for <z:mpath ids='MPATH_3'>apoptosis</z:mpath> induction in response to DNA damage </plain></SENT>
<SENT sid="3" pm="."><plain>In fact, p53 mediates DNA repair and protective responses in the latter cell types, in some cases p53-deficient cells being more sensitive to DNA damage, antithetical to the situation in Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and other <z:mpath ids='MPATH_3'>apoptosis</z:mpath>-prone cell types </plain></SENT>
<SENT sid="4" pm="."><plain>Ultraviolet light, <z:chebi fb="2" ids="27899">cisplatin</z:chebi>, and <z:chebi fb="0" ids="28925,37598">nitrogen mustards</z:chebi> produce damage that is repaired by a p53-regulated pathway </plain></SENT>
<SENT sid="5" pm="."><plain>Here, we explore the sensitivity of the <z:chebi fb="240" ids="33364,33400">platinum</z:chebi> compound <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> and <z:chebi fb="1" ids="29830">thio</z:chebi>-TEPA (N, N', N", triethylenethiophosphoramide), a <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> chemotherapeutic agent that produces largely base damage, in p53-defective cells </plain></SENT>
<SENT sid="6" pm="."><plain>This work demonstrates that the contribution of p53 temporally correlates with DNA repair pathways to produce a resistant phenotype, while the p53-defective cells are more sensitive to certain DNA-damaging chemotherapeutic agents </plain></SENT>
</text></document>